Potokar M, Schmidt-Dunker M
Atherosclerosis. 1978 Aug;30(4):313-20. doi: 10.1016/0021-9150(78)90124-7.
Three new diphosphonic acids, i.e. compounds containing a P-C-P bond, have been investigated for their ability to inhibit the vitamin D-induced calcification of aortas and kidneys in rats. The compounds were applied orally in various doses. All of the compounds, which had previously been shown to effectively inhibit the in vitro crystallization of apatite, markedly decreased the amount of calcium deposited in aortas and kidneys. One of the new compounds was substantially more effective than ethane-1-hydroxy-1,1-diphosphonic acid (EHDP), which was used as a reference compound. Diphosphonic acids might be used therapeutically in man against soft tissue calcification.
三种新的二膦酸,即含有P-C-P键的化合物,已被研究其抑制维生素D诱导的大鼠主动脉和肾脏钙化的能力。这些化合物以不同剂量口服给药。所有这些先前已被证明能有效抑制磷灰石体外结晶的化合物,都显著减少了主动脉和肾脏中钙的沉积量。其中一种新化合物比用作参考化合物的乙烷-1-羟基-1,1-二膦酸(EHDP)效果显著更好。二膦酸可能在治疗人类软组织钙化方面有应用价值。